| 1/24/2022 | 3002150000 | SAR650984 ( IZATUXIMAB), 20 MG/ML INTRAVENOUS SOLUTION CONCENTRATE IN 25 ML BOTTLE (500 MG/25 ML), 28 BOTTLE TOTAL, SERIES IP0011220, EXPIRY 12/2022, : | 1.85 | 29308.2 | Germany | Unknown | REPRESENTATIVE OFFICE OF AO SANOFI AVENTIS GROUP FRANCE |
| 1/18/2022 | 3002150000 | SAR441344 / PLACEBO, 150 MG/ML SUBCUTANEOUS AND INTRAVENOUS SOLUTION, 2 ML EACH, 1 VIAL IN A CARTON, 368 VIALS TOTAL : | 10.43 | 55908.3 | United States of America | UNKNOWN | REPRESENTATIVE OFFICE OF AO SANOFI AVENTIS GROUP FRANCE |
| 1/27/2022 | 3002150000 | TISLELIZUMAB (BGB-A317), 100 mg/10 ml intravenous solution concentrate or placebo in vial - 18 vials, lot 234940010, EXPIRY DATE 02/19/2023 | 0.3 | 1261.31 | China | Unknown | PAREXEL INTERNATIONAL RUS LLC |